KIT and Miyoshi myopathy: In MM, tumor plasma cells with a mature phenotype gain a certain degree of phenotypic plasticity by expressing specific stem cell progenitor markers, such as SOX2, MAGE, CD117 (KIT), and Nestin [96,97,98,99].